Press Release June 27, 2018

 In General Updates, Hot Topics, Press Releases

FOR IMMEDIATE RELEASE                                             For More Information, contact:

June 27, 2018                                                                          Randy Miller, 317-254-2815




Randy Miller, Executive Director, released the following statement regarding the FDA’s recent approval of the first cannabidiol medication, Epidiolex:

“The FDA recently approved a CBD-based medication, Epidiolex, which is for treatment of two rare and severe epileptic disorders. This is noteworthy because it will make available a proven and safe medication for patients derived from components found in marijuana. It also demonstrates that science can and should be leading the way in developing medicines from cannabis plant rather than unregulated policies or the marijuana industry.”

Epidiolex is a pharmaceutical-grade version of CBD oil which comes in a flavored syrup that reduces seizures. It does not contain THC, the psychoactive ingredient in cannabis, nor other dangerous substances that have been found in some commercially marketed oils. The FDA has cautioned that the benefits from unapproved and unregulated CBD products may be overstated and, in fact, potentially harmful.

In announcing this new medication, FDA Commissioner Scott Gottelib made the following important point: “This is an important medical advance. But it’s also important to note that this is not an approval of marijuana or all of its components. This is the approval of one specific CBD medication for a specific use.”

Drug Free Marion County commends the FDA for this action and supports continued study and research to determine any medical value that can be derived from marijuana that will be both safe and effective for patients.

Contact Us

You can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt